Finance

Beta
Lists
002294:SHE
Shenzhen Salubris Pharmaceuticals Co Ltd
CN¥32.28
+0.59%
(+0.19) 1D
Jun 5, 3:04:09 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002294...
Open
CN¥32.43
High
CN¥33.42
Low
CN¥32.15
Mkt. cap
36.04B
Avg. vol.
21.23M
Volume
20.77M
Dividend
1.70%
Quarterly dividend
CN¥0.14
Ex-dividend date
May 26, 2026
P/E ratio
53.20
52-wk high
CN¥70.99
52-wk low
CN¥31.72
EPS
CN¥0.61
Shares outstanding
1.11B
No. of employees
4K
Open
CN¥32.43
High
CN¥33.42
Low
CN¥32.15
Mkt. cap
36.04B
Avg. vol.
21.23M
Volume
20.77M
Dividend
1.70%
Quarterly dividend
CN¥0.14
Ex-dividend date
May 26, 2026
P/E ratio
53.20
52-wk high
CN¥70.99
52-wk low
CN¥31.72
EPS
CN¥0.61
Shares outstanding
1.11B
No. of employees
4K
News stories
From sources across the web
Profile
Shenzhen Salubris Pharmaceuticals is a Chinese pharmaceutical company. Founded in November 1998 and based in Shenzhen, it has a market cap of US$4.4 billion, 3,121 employees and annual sales of $553 million as of 2019. Shenzhen Salubris is headed by the billionaire Ye Chenghai. Wikipedia
About Shenzhen Salubris Pharmaceuticals Co Ltd
CEO-
Employees4.09K
FoundedNov 3, 1998
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.07B
1.11B
1.11B
1.23B
Cost of goods sold
260.77M
279.29M
302.88M
287.67M
Cost of revenue
260.77M
279.29M
302.88M
287.67M
Research and development expenses
127.13M
127.63M
176.44M
131.32M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
500.85M
486.77M
568.30M
551.61M
Operating expense
657.64M
595.66M
770.11M
694.36M
Total operating expenses
918.41M
874.96M
1.07B
982.03M
Operating income
150.35M
235.37M
38.38M
246.41M
Other non operating income
4.22M
-14.62M
13.83M
-5.27M
EBT including unusual items
188.65M
234.09M
5.21M
255.47M
EBT excluding unusual items
170.27M
246.15M
72.00M
252.02M
Income tax expense
16.14M
18.06M
-56.18M
29.65M
Effective tax rate
8.56%
7.72%
-1,078.48%
11.60%
Other operating expenses
17.35M
-17.83M
34.11M
9.61M
Net income
164.75M
215.63M
70.80M
225.27M
Net profit margin
15.41%
19.42%
6.37%
18.34%
Earnings per share
-
-
-
-
Interest and investment income
24.07M
26.87M
37.76M
15.05M
Interest expense
-4.97M
-4.88M
-7.50M
-4.17M
Net interest expenses
19.10M
22.00M
30.27M
10.88M
Depreciation and amortization charges
-
-
-
-
EBITDA
245.21M
325.52M
135.48M
343.52M
Gain or loss from assets sale
983.77K
-983.77K
3.03M
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more